Cargando…

Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study

OBJECTIVES: To date, reported SARS-CoV-2 reinfection cases are mainly from strains belonging to different clades. As the pandemic advances, a few lineages have become dominant in certain areas leading to reinfections by similar strains. Here, we report a reinfection case within the same clade of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevillano, Gabriela, Ortega-Paredes, David, Loaiza, Karen, Zurita-Salinas, Camilo, Zurita, Jeannete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078048/
https://www.ncbi.nlm.nih.gov/pubmed/33930542
http://dx.doi.org/10.1016/j.ijid.2021.04.073
_version_ 1783684995666149376
author Sevillano, Gabriela
Ortega-Paredes, David
Loaiza, Karen
Zurita-Salinas, Camilo
Zurita, Jeannete
author_facet Sevillano, Gabriela
Ortega-Paredes, David
Loaiza, Karen
Zurita-Salinas, Camilo
Zurita, Jeannete
author_sort Sevillano, Gabriela
collection PubMed
description OBJECTIVES: To date, reported SARS-CoV-2 reinfection cases are mainly from strains belonging to different clades. As the pandemic advances, a few lineages have become dominant in certain areas leading to reinfections by similar strains. Here, we report a reinfection case within the same clade of the initial infection in a symptomatic 28-year-old-male in Quito-Ecuador. METHODS: Infection was detected by reverse transcription-polymerase chain reaction, and immune response evaluated by antibody testing. Whole-genome sequencing was performed and phylogenetic analysis conducted to determine relatedness. RESULTS: Both the infection and the reinfection strains were assigned as Nextstrain 20B, Pangolin lineage B.1.1 and GISAID clade O. Our analysis indicated 4–6 fold more nucleotide changes than are expected for reactivation or persistence compared with the natural rate of SARS-CoV-2 mutation (∼2–3 nucleotide changes per month), thus supporting reinfection. Furthermore, approximately 3 months after the second infection, COVID-19 antibodies were not detectable in the patient, suggesting potential vulnerability to a third infection. CONCLUSIONS: Our results showed evidence of SARS-CoV-2 reinfection within the same clade in Ecuador, indicating that previous exposure to SARS-CoV-2 does not guarantee immunity in all cases.
format Online
Article
Text
id pubmed-8078048
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-80780482021-04-28 Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study Sevillano, Gabriela Ortega-Paredes, David Loaiza, Karen Zurita-Salinas, Camilo Zurita, Jeannete Int J Infect Dis Article OBJECTIVES: To date, reported SARS-CoV-2 reinfection cases are mainly from strains belonging to different clades. As the pandemic advances, a few lineages have become dominant in certain areas leading to reinfections by similar strains. Here, we report a reinfection case within the same clade of the initial infection in a symptomatic 28-year-old-male in Quito-Ecuador. METHODS: Infection was detected by reverse transcription-polymerase chain reaction, and immune response evaluated by antibody testing. Whole-genome sequencing was performed and phylogenetic analysis conducted to determine relatedness. RESULTS: Both the infection and the reinfection strains were assigned as Nextstrain 20B, Pangolin lineage B.1.1 and GISAID clade O. Our analysis indicated 4–6 fold more nucleotide changes than are expected for reactivation or persistence compared with the natural rate of SARS-CoV-2 mutation (∼2–3 nucleotide changes per month), thus supporting reinfection. Furthermore, approximately 3 months after the second infection, COVID-19 antibodies were not detectable in the patient, suggesting potential vulnerability to a third infection. CONCLUSIONS: Our results showed evidence of SARS-CoV-2 reinfection within the same clade in Ecuador, indicating that previous exposure to SARS-CoV-2 does not guarantee immunity in all cases. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-07 2021-04-27 /pmc/articles/PMC8078048/ /pubmed/33930542 http://dx.doi.org/10.1016/j.ijid.2021.04.073 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sevillano, Gabriela
Ortega-Paredes, David
Loaiza, Karen
Zurita-Salinas, Camilo
Zurita, Jeannete
Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
title Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
title_full Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
title_fullStr Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
title_full_unstemmed Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
title_short Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
title_sort evidence of sars-cov-2 reinfection within the same clade in ecuador: a case study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078048/
https://www.ncbi.nlm.nih.gov/pubmed/33930542
http://dx.doi.org/10.1016/j.ijid.2021.04.073
work_keys_str_mv AT sevillanogabriela evidenceofsarscov2reinfectionwithinthesamecladeinecuadoracasestudy
AT ortegaparedesdavid evidenceofsarscov2reinfectionwithinthesamecladeinecuadoracasestudy
AT loaizakaren evidenceofsarscov2reinfectionwithinthesamecladeinecuadoracasestudy
AT zuritasalinascamilo evidenceofsarscov2reinfectionwithinthesamecladeinecuadoracasestudy
AT zuritajeannete evidenceofsarscov2reinfectionwithinthesamecladeinecuadoracasestudy